Effectiveness and clinical predictors of a virtual based combined cognitive behavioral and motivational enhancement group therapy for adults with cannabis use disorder.
Effectiveness and clinical predictors of a virtual based combined cognitive behavioral and motivational enhancement group therapy for adults with cannabis use disorder.
Virtual 12-week CBT-MET group therapy demonstrated effectiveness for cannabis use disorder with high completion rates in a real-world clinical setting.
This study provides real-world evidence that virtual delivery of established CBT-MET protocols can maintain clinical effectiveness for cannabis use disorder. The retrospective design captures how these interventions perform in actual clinical practice rather than controlled research settings.
Virtual addiction treatment became essential during COVID-19 and remains an important access option. This data supports virtual CBT-MET as a viable treatment modality for CUD when in-person care is unavailable or impractical.
| Study Type | Retrospective Cohort Study |
| Population | 116 adults with cannabis use disorder, virtual group therapy setting, 2020-2023 |
| Intervention | 12-week virtual group-based cognitive behavioral therapy plus motivational enhancement therapy (CBT-MET) |
| Comparator | Pre-post treatment comparison |
| Primary Outcome | Cannabis use frequency, depression (PHQ-9), anxiety (GAD-7), craving (MCQ), and problematic use (CUDIT) |
| Key Finding | Significant improvements in cannabis use patterns and psychological symptoms among treatment completers (≥75% attendance) |
| Journal | Drug and Alcohol Dependence |
| Year | 2024 |
Virtual group-based CBT-MET appears effective for motivated adults with CUD who can maintain consistent attendance. The 75% attendance threshold suggests engagement remains crucial for benefit regardless of delivery modality.
This study cannot establish whether virtual delivery is superior, inferior, or equivalent to in-person treatment since no comparison group was included. Long-term durability of treatment effects is also unknown.
The retrospective design introduces selection bias toward treatment completers. Self-reported cannabis use lacks biological verification, and baseline predictors of response are mentioned but not detailed in the abstract.
Virtual CBT-MET represents a practical, evidence-supported option for CUD treatment with real-world effectiveness data. Treatment engagement remains the key variable regardless of delivery method, and virtual formats may enhance accessibility without compromising outcomes.
Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
FAQ
Is virtual group therapy effective for treating cannabis use disorder?
Yes, this study demonstrated that a 12-week virtual group-based CBT-MET program was clinically effective for adults with cannabis use disorder. Participants who completed the program (≥75% attendance) showed significant improvements in cannabis use, craving, and problematic use measures, indicating that virtual delivery can be an effective treatment modality.
What is the completion rate for virtual cannabis use disorder treatment?
The study found high completion rates for the virtual CBT-MET program, with participants achieving ≥75% attendance considered completers. This suggests that virtual group therapy format has good acceptability and feasibility for individuals seeking treatment for cannabis use disorder.
Can virtual therapy help reduce cannabis cravings and problematic use patterns?
Yes, the study showed significant reductions in cannabis craving (measured by MCQ) and problematic cannabis use (measured by CUDIT) from baseline to post-treatment. These improvements were observed alongside reductions in actual cannabis use frequency among program completers.
Does virtual CBT-MET also address co-occurring mental health symptoms?
The study found that participants experienced improvements in both depression (PHQ-9) and anxiety (GAD-7) scores during the 12-week virtual treatment program. This suggests that virtual CBT-MET may provide additional mental health benefits beyond addressing cannabis use specifically.
What baseline factors predict better treatment outcomes in virtual cannabis treatment?
The researchers examined baseline predictors of treatment response using linear mixed models to identify which patient characteristics were associated with better outcomes. While specific predictor results weren’t detailed in the summary, this analysis helps clinicians understand which patients may benefit most from virtual CBT-MET interventions.
